Primary Malignant Skull Tumors Follow-up

Updated: Aug 09, 2017
  • Author: Draga Jichici, MD, FRCP, FAHA; Chief Editor: Tarakad S Ramachandran, MBBS, MBA, MPH, FAAN, FACP, FAHA, FRCP, FRCPC, FRS, LRCP, MRCP, MRCS  more...
  • Print
Follow-up

Further Outpatient Care

See the list below:

  • Postoperative

  • Radiation therapy

  • Chemotherapy

Next:

Further Inpatient Care

See the list below:

  • Postoperative

  • Chemotherapy

Previous
Next:

Complications

See the list below:

  • Postoperative complications

    • Cranial nerve palsy

    • Meningitis

    • Paralysis

    • Cognitive dysfunction

  • Carcinomatous meningitis

  • Wound infection

  • Immunosuppression due to chemotherapy and radiation therapy

  • Recurrence

  • Metastasis

Previous
Next:

Prognosis

See the list below:

  • Osteosarcoma has a 5-year survival rate between 20% and 50%.

  • Chondrosarcoma has a 10-year survival rate of 30-80%, depending on the grade of the initial tumor.

  • Fibrosarcomas metastasize in 50% of cases, and the 10-year survival rate is 40%.

  • Ewing sarcoma has a 5-year survival rate of 40-65%.

  • Giant cell tumor has a recurrence rate of 30% in 2 years, but otherwise its prognosis is relatively good.

  • Angiosarcomas, if properly treated, have a cure rate of about 50%.

  • Chordomas, although difficult to resect completely, are slow-growing tumors and have a 5-year survival rate of 40%.

  • Myeloma survival rates vary depending on the grade. However, even in patients with widespread disease, complete remission can be achieved for up to 2-3 years (or longer).

Previous
Next:

Patient Education

See the list below:

  • The lesion should be identified and treated promptly.

  • If required, patients should be referred for psychological counseling.

Previous